SCHEMBL6000128

SCHEMBL6000128

CCOC(=O)CNCc1nc2ccccc2n1C

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 9/20 0.61
RAB9A P51151 9/20 0.61
MAPT P10636 2/20 0.55
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
SMN1; SMN2 Q16637 4/20 0.52
LMNA P02545 2/20 0.52
KDM4E B2RXH2 4/20 0.51
ALDH1A1 P00352 4/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
PKM P14618 1/20 0.51
TP53 P04637 1/20 0.51
ALOX15 P16050 1/20 0.51
NFKB1 P19838 1/20 0.51
NFKB2 Q00653 1/20 0.51
RELA Q04206 1/20 0.51
GAA P10253 2/20 0.50
HDAC6 Q9UBN7 1/20 0.50
TSHR P16473 1/20 0.49
HSD17B10 Q99714 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6000120 0.99 NPC1 (0.60) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL7018296 0.83 RAB9A (0.58) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL5608972 0.79 NPC1 (0.73) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL13972841 0.78 NPC1 (0.67) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL2937868 0.77 MAPT (0.72) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL2816362 0.77 NPC1 (0.55) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL30605183 0.76 NPC1 (0.69) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL32688299 0.75 KDM4E (0.57) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL8401361 0.75 MAPT (0.69) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL2816742 0.75 NPC1 (0.55) NPC1RAB9AMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US disclosed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof PTPN11, PTPN1, PTPN3 NPC1 955/4885RAB9A 1393/4885MAPT 4785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.